A perspective on RNA interference-based therapeutics for metabolic liver diseases
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2021.1879792
Abstract: ABSTRACT Introduction: Therapeutic oligonucleotides have emerged as a promising new class of drug that could silence undruggable targets; they can potentially treat metabolic liver diseases such as nonalcoholic fatty liver disease (NAFLD), hereditary hemochromatosis and… read more here.
Keywords: liver diseases; rna interference; metabolic liver; perspective rna ... See more keywords